scispace - formally typeset
J

James Sayre

Researcher at University of California, Los Angeles

Publications -  313
Citations -  19463

James Sayre is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Aneurysm & Internal medicine. The author has an hindex of 73, co-authored 295 publications receiving 18152 citations. Previous affiliations of James Sayre include UCLA Medical Center & California State University, Fresno.

Papers
More filters
Journal ArticleDOI

Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT.

TL;DR: A grading system for tumor involvement of the major vessels in patients with pancreatic adenocarcinoma can be based on the degree of circumferential contiguity of tumor to vessel.
Journal ArticleDOI

Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect.

TL;DR: There appears to be a narrow transition zone for hepatic vessels at 2-4 mm, beyond which the heat sink effect was seen consistently and substantial vascular injury was rare.
Journal Article

Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography.

TL;DR: CTA has a higher sensitivity and positive predictive value than MRA and is recommended over 3D time-of-flight MRA for detection of intracranial stenosis and occlusion and has a significant effect on patient clinical management.
Journal ArticleDOI

Uterine Artery Embolization for the Treatment of Uterine Leiomyomata Midterm Results

TL;DR: Uterine artery embolization for the treatment of uterine fibroids is a minimally invasive technique with low complication rates and very good clinical efficacy.
Journal ArticleDOI

Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors.

TL;DR: Multivariate logistic regression analysis showed that presence or absence of a large peritumoral vessel is an independent, and the dominant, predictor of treatment outcome of incomplete tumor destruction by RF ablation.